DIA
Drug Information Association Logo

Pharmaceutical Industry Global Regulatory Authorities and Allied Working Groups Collaborate to Advance Drug Development in Latin America

Horsham, PA, USA — Mar 16, 2011

DIA will host the 3rd Annual Latin American Regulatory Conference: Harmonization of Regulatory Requirements in Drug Development and Registration from April 12-15, 2011 in Panama City, Panama. This four-day conference will discuss the progress of the PANDRH harmonization process and attempt to define the global regulatory environment and its impact on access to medicine and the future of R&D in Latin America. Specific discussion topics will include:

  • Current Environment for Regulatory Authorities and Industry for Latin America
  • Harmonization Initiatives, Regulatory Landscape and Clinical Trials in the Latin American Region
  • Good Clinical Research Practice
  • Drug Safety, Good Clinical and Regulatory Practices Across Latin America
  • Pharmacovigilance
  • Biotechnology
  • Transparency and Predictability
  • Emerging Topics 

“From an evolving series of Latin American Regulatory Conferences (LARC) held in May 2008 and November 2009 comes this alliance for key stakeholders to influence the advancement for harmonization initiatives within the Latin American local regions,” says Latin American Steering Committee Member Sergio Guerrero, MD, Director, OCA Hospital/Monterrey International Research Center, Mexico.

 

 

 

 

###

ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.